| Literature DB >> 34837085 |
Yi Xuan1,2, Subhadip Ghatak3, Andrew Clark3, Zhigang Li4, Savita Khanna3, Dongmin Pak5, Mangilal Agarwal6, Sashwati Roy3,7, Peter Duda8, Chandan K Sen9,10.
Abstract
Tissue nanotransfection (TNT) is an electromotive gene transfer technology that was developed to achieve tissue reprogramming in vivo. This protocol describes how to fabricate the required hardware, commonly referred to as a TNT chip, and use it for in vivo TNT. Silicon hollow-needle arrays for TNT applications are fabricated in a standardized and reproducible way. In <1 s, these silicon hollow-needle arrays can be used to deliver plasmids to a predetermined specific depth in murine skin in response to pulsed nanoporation. Tissue nanotransfection eliminates the need to use viral vectors, minimizing the risk of genomic integration or cell transformation. The TNT chip fabrication process typically takes 5-6 d, and in vivo TNT takes 30 min. This protocol does not require specific expertise beyond a clean room equipped for basic nanofabrication processes.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34837085 PMCID: PMC9104164 DOI: 10.1038/s41596-021-00631-0
Source DB: PubMed Journal: Nat Protoc ISSN: 1750-2799 Impact factor: 17.021